Overview

This is a Single Ascending Dose Tolerance Study

Status:
Terminated
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
This is a single rising dose tolerance (Part A) followed by a functional magnetic resonance imaging (Part B)
Phase:
Phase 1
Details
Lead Sponsor:
Abbott
Collaborator:
Quintiles, Inc.